XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023     4,975,000 696,242,668          
Beginning balance at Dec. 31, 2023 $ 58,089 $ (25) $ 0 $ 7 $ 35,541 $ 60,945 $ (25) $ (8,268) $ (30,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 14         1,280   (1,266)  
Dividends—common stock (in shares) [2]       24,969          
Dividends—common stock [2] (235)     $ 0 3 (238)      
Dividends—preferred stock (57)         (57)      
Purchases of treasury stock (249)               (249)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       3,470,983          
Issuances of common stock and restricted stock, net of forfeitures 80     $ 0 80        
Exercises of stock options (in shares)       15,000          
Exercises of stock options 1     $ 0 1        
Compensation expense for restricted stock units 183       183        
Ending balance (in shares) at Mar. 31, 2024     4,975,000 699,753,620          
Ending balance at Mar. 31, 2024 57,801   $ 0 $ 7 35,808 61,905   (9,534) (30,385)
Beginning balance (in shares) at Dec. 31, 2023     4,975,000 696,242,668          
Beginning balance at Dec. 31, 2023 58,089 $ (25) $ 0 $ 7 35,541 60,945 $ (25) (8,268) (30,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 5,635                
Ending balance (in shares) at Sep. 30, 2024     4,975,000 701,557,753          
Ending balance at Sep. 30, 2024 62,925   $ 0 $ 7 36,216 63,698   (6,287) (30,709)
Beginning balance (in shares) at Mar. 31, 2024     4,975,000 699,753,620          
Beginning balance at Mar. 31, 2024 57,801   $ 0 $ 7 35,808 61,905   (9,534) (30,385)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 430         597   (167)  
Dividends—common stock (in shares) [2]       8,354          
Dividends—common stock [2] (232)     $ 0 2 (234)      
Dividends—preferred stock (57)         (57)      
Purchases of treasury stock (163)               (163)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       941,120          
Issuances of common stock and restricted stock, net of forfeitures 95     $ 0 95        
Compensation expense for restricted stock units 107       107        
Ending balance (in shares) at Jun. 30, 2024     4,975,000 700,703,094          
Ending balance at Jun. 30, 2024 57,981   $ 0 $ 7 36,012 62,211   (9,701) (30,548)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 5,191         1,777   3,414  
Dividends—common stock (in shares) [2]       2,846          
Dividends—common stock [2] (233)     $ 0 0 (233)      
Dividends—preferred stock (57)         (57)      
Purchases of treasury stock (161)               (161)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       691,072          
Issuances of common stock and restricted stock, net of forfeitures 76     $ 0 76        
Exercises of stock options (in shares)       160,741          
Exercises of stock options 3     $ 0 3        
Compensation expense for restricted stock units 125       125        
Ending balance (in shares) at Sep. 30, 2024     4,975,000 701,557,753          
Ending balance at Sep. 30, 2024 62,925   $ 0 $ 7 36,216 63,698   (6,287) (30,709)
Beginning balance (in shares) at Dec. 31, 2024     4,975,000 702,224,674          
Beginning balance at Dec. 31, 2024 60,784   $ 0 $ 7 36,428 64,505   (9,286) (30,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 3,161         1,404   1,757  
Dividends—common stock (in shares) [2]       12,211          
Dividends—common stock [2] (234)     $ 0 2 (236)      
Dividends—preferred stock (57)         (57)      
Purchases of treasury stock (375)               (375)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       3,572,356          
Issuances of common stock and restricted stock, net of forfeitures 93     $ 0 93        
Exercises of stock options (in shares)       14,070          
Exercises of stock options 1     $ 0 1        
Compensation expense for restricted stock units 169       169        
Ending balance (in shares) at Mar. 31, 2025     4,975,000 705,823,311          
Ending balance at Mar. 31, 2025 63,542   $ 0 $ 7 36,693 65,616   (7,529) (31,245)
Beginning balance (in shares) at Dec. 31, 2024     4,975,000 702,224,674          
Beginning balance at Dec. 31, 2024 60,784   $ 0 $ 7 36,428 64,505   (9,286) (30,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 3,688                
Ending balance (in shares) at Sep. 30, 2025     4,980,700 707,690,438          
Ending balance at Sep. 30, 2025 113,813   $ 0 $ 7 63,725 63,624   (5,917) (7,626)
Beginning balance (in shares) at Mar. 31, 2025     4,975,000 705,823,311          
Beginning balance at Mar. 31, 2025 63,542   $ 0 $ 7 36,693 65,616   (7,529) (31,245)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) (3,567)         (4,277)   710  
Dividends—common stock (in shares) [2]       2,163          
Dividends—common stock [2] (388)     $ 0 0 (388)      
Dividends—preferred stock (65)         (65)      
Purchases of treasury stock (167)               (167)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       903,641          
Issuances of common stock and restricted stock, net of forfeitures 111     $ 0 111        
Reissuance of treasury stock related to the Transaction 50,586     $ 0 25,763       24,823
Issuances of preferred stock related to the Transaction (in shares)     10,700            
Issuances of preferred stock related to the Transaction 1,068   $ 0   1,068        
Redemptions of preferred stock (shares)     (5,000)            
Redemptions of preferred stock (500)   $ 0   (506) 6      
Compensation expense for restricted stock units 214       214        
Fair value of purchase consideration related to restricted stock units 122       122        
Ending balance (in shares) at Jun. 30, 2025     4,980,700 706,729,115          
Ending balance at Jun. 30, 2025 110,956   $ 0 $ 7 63,465 60,892   (6,819) (6,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Comprehensive income (loss) 4,094         3,192   902  
Dividends—common stock (in shares) [2]       2,597          
Dividends—common stock [2] (386)     $ 0 1 (387)      
Dividends—preferred stock (73)         (73)      
Purchases of treasury stock (1,037)               (1,037)
Issuances of common stock and restricted stock, net of forfeitures (in shares)       958,726          
Issuances of common stock and restricted stock, net of forfeitures 91     $ 0 91        
Compensation expense for restricted stock units 168       168        
Ending balance (in shares) at Sep. 30, 2025     4,980,700 707,690,438          
Ending balance at Sep. 30, 2025 $ 113,813   $ 0 $ 7 $ 63,725 $ 63,624   $ (5,917) $ (7,626)
[1] Impact from the adoption of Accounting Standards Update (“ASU”) 2023-02, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method as of January 1, 2024.
[2] We declared dividends per share on our common stock of $0.60 in both the third quarter of 2025 and 2024, and $1.80 in both the first nine months of 2025 and 2024.